Clin2
NCT07363733Possibly a fitRecruiting

Comparing radiofrequency vs steroid cream for vulvar lichen sclerosus

Vulvar Lichen Sclerosus

Part of Women’s health & pregnancy clinical trials.

This study compares a new non-invasive treatment using radiofrequency energy to a standard steroid cream for women with vulvar lichen sclerosus. The goal is to see which works better for symptom relief.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
68 people
Ages
18 years to 49 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 49 years old
  • You have been diagnosed with vulvar lichen sclerosus through a biopsy
  • You are not pregnant or breastfeeding
  • You have not used steroid cream on the area in the last 3 months
  • You do not have an active infection (including STIs, hepatitis B, hepatitis C, or syphilis)
  • You do not have a pacemaker or a copper IUD

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07240389Not yet recruiting
New treatments for vulvar lichen sclerosus

This trial compares three treatments for vulvar lichen sclerosus: a steroid ointment, a non-steroid ointment, and platelet-rich plasma therapy. It aims to see which works best for managing symptoms and improving skin health.

Krakow, Małopolska
NCT07240519Recruiting
Comparing clobetasol cream vs CO2 laser for vulvar lichen sclerosus

This study compares two treatments—clobetasol steroid cream or a fractional CO2 laser—for women with vulvar lichen sclerosus who have not used steroid cream before. It looks at how inflammation changes after treatment.

Rio de Janeiro, Rio de Janeiro
NCT06662942Recruiting· Phase 1
Testing StrataMGT for vulvar lichen sclerosus symptoms

This study tests whether a new topical treatment, StrataMGT, can reduce symptoms of vulvar lichen sclerosus. It is for women with moderate to severe symptoms who are already using a stable topical prescription.

Washington D.C., District of Columbia
NCT07352917Recruiting· Phase 2
Methotrexate for severe vulvar lichen sclerosus

This study tests the drug methotrexate as a treatment for severe vulvar lichen sclerosus that has not responded to strong steroid creams. It aims to see if methotrexate can reduce symptoms and prevent further scarring.

São José dos Campos, São Paulo
NCT06661382Recruiting· Phase 1/Phase 2
Cord blood plasma vs placebo for vulvar lichen sclerosus

This study tests whether a shot of concentrated healing cells from umbilical cord blood (called platelet-rich plasma) can help treat vulvar lichen sclerosus better than a placebo shot. It aims to find a new, safe option for women who are not helped by standard treatments.

Milan, Milan
NCT06389071Recruiting
Laser treatment for lichen sclerosus

This study tests a laser treatment for women with vulvar lichen sclerosus to see if it can help with symptoms like itching, burning, pain, or soreness. It's a option for those who have had a biopsy to confirm the condition.

Val-d'Or, Quebec

Hear when a new Vulvar Lichen Sclerosus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.